Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs

Overview of attention for article published in Cancer Immunology Research, December 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

patent: 1 patent

Citations

dimensions_citation: 152 Dimensions

Readers on

mendeley: 127 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 152 publications that cite this research output.

152

The most recent citing publications are shown below. View all 152 publications that cite this research output on Dimensions.

Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies

Article in Biomedicine & Pharmacotherapy (April 2024)

Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer

Article in Prostate Cancer and Prostatic Diseases (April 2024)

MS275 induces tumor immunosuppression by up-regulating PD-L1 and enhances the efficacy of anti-PD-1 immunotherapy in colorectal cancer

Preprint in Research Square (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.